Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze TARS stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate TARS investment potential.

What is TARS stock price today?

Get real-time TARS stock price, historical data, and price charts on Financhill. Track TARS performance with our advanced analysis tools.

Is TARS a good investment?

Evaluate TARS investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy TARS stock?

To buy TARS stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of TARS?

View detailed market capitalization data and company valuation metrics for TARS on our comprehensive analysis page.

What is the P/E ratio of TARS?

Use our fundamental analysis tools to view TARS P/E ratio and compare valuation metrics with industry peers.

What are TARS earnings?

View TARS earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Tarsus Pharmaceuticals, Inc. Stock Predictions

14K Investors Got In Earlier. You Still Can.

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

Sell

TARS
Tarsus Pharmaceuticals, Inc.

Last Price:

$77.57

Seasonality Move:

-3.01%

7 Day Trial

ALL ACCESS PASS

$ 7

Share Price Moved. Momentum Hasn't Slowed.

Tarsus Pharmaceuticals, Inc. Stock Forecast

Over the next 52 weeks, Tarsus Pharmaceuticals, Inc. has on average historically risen by 33.4% based on the past 5 years of stock performance.
Tarsus Pharmaceuticals, Inc. has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
Is Tarsus Pharmaceuticals, Inc. Stock Undervalued?

The current Tarsus Pharmaceuticals, Inc. [TARS] share price is $77.77. The Score for TARS is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
TARS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Tarsus Pharmaceuticals, Inc. Stock Go Up Next Year?

Over the next 52 weeks, Tarsus Pharmaceuticals, Inc. has on average historically risen by 33.4% based on the past 5 years of stock performance.

Tarsus Pharmaceuticals, Inc. Stock Rating

Sell

Tarsus Pharmaceuticals, Inc. (TARS) is a Sell

Is Tarsus Pharmaceuticals, Inc. overpriced?

Tarsus Pharmaceuticals, Inc. has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%

Tarsus Pharmaceuticals, Inc. Stock Price History

Is TARS stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TARS is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Pharmaceuticals

Sector:

Health Care

Type:

stock

Website:

tarsusrx.com

52-Week Data

52-Week High:

85.25

52-Week Low:

38.51

Prediction Charts

Market Cap:

3.3B

Price in USD:

77.77

Volume:

794.6K

Beta:

0.81

Technical Analysis

SMA50:

74.56

SMA100:

64.12

SMA200:

54.53

52-Wk Change:

46.02%

Stock Predictions

Is Tarsus Pharmaceuticals, Inc. stock public?

Yes, Tarsus Pharmaceuticals, Inc. is a publicly traded company.
What is the Tarsus Pharmaceuticals, Inc. stock quote today?

The Tarsus Pharmaceuticals, Inc. stock price is 77.77 USD today.
How to buy Tarsus Pharmaceuticals, Inc. stock online?

You can buy Tarsus Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Nov-28	80.00	79.96	80.99	79.70
Dec-1	79.67	79.97	80.61	77.44
Dec-2	79.99	79.44	81.96	78.35
Dec-3	79.89	81.88	81.98	79.32
Dec-4	81.90	81.83	82.90	80.14
Dec-5	81.98	81.77	82.23	80.65
Dec-8	82.69	82.23	83.78	81.50
Dec-9	83.16	79.55	85.25	79.46
Dec-10	79.58	81.32	81.70	78.10
Dec-11	81.60	81.70	82.69	80.75
Dec-12	82.33	81.35	83.34	80.51
Dec-15	81.63	80.48	83.27	80.21
Dec-16	80.10	78.28	81.08	77.69
Dec-17	78.42	77.77	79.77	77.63

Tarsus Pharmaceuticals, Inc. Earnings

Tarsus Pharmaceuticals, Inc. Earnings Report: Per Share Tarsus Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Tarsus Pharmaceuticals, Inc. Forecast Revenue Growth

Tarsus Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for Tarsus Pharmaceuticals, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.62 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.67 per share, and an increase next year of $2.75 per share.

* Tarsus Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.